Literature DB >> 29545281

Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: Highlights from basic research to therapy.

Alice Huertas1,2, Christophe Guignabert1,2, Joan A Barberà3,4, Peter Bärtsch5, Jahar Bhattacharya6, Sunita Bhattacharya6, Maria R Bonsignore7, Laurence Dewachter8, Anh Tuan Dinh-Xuan9, Peter Dorfmüller1, Mark T Gladwin10, Marc Humbert1, Tom Kotsimbos11, Theodoros Vassilakopoulos12, Olivier Sanchez13, Laurent Savale1, Ugo Testa14, Martin R Wilkins15.   

Abstract

The European Respiratory Society (ERS) Research Seminar entitled "Pulmonary vascular endothelium: orchestra conductor in respiratory diseases - highlights from basic research to therapy" brought together international experts in dysfunctional pulmonary endothelium, from basic science to translational medicine, to discuss several important aspects in acute and chronic lung diseases. This review will briefly sum up the different topics of discussion from this meeting which was held in Paris, France on October 27-28, 2016. It is important to consider that this paper does not address all aspects of endothelial dysfunction but focuses on specific themes such as: 1) the complex role of the pulmonary endothelium in orchestrating the host response in both health and disease (acute lung injury, chronic obstructive pulmonary disease, high-altitude pulmonary oedema and pulmonary hypertension); and 2) the potential value of dysfunctional pulmonary endothelium as a target for innovative therapies.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29545281     DOI: 10.1183/13993003.00745-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium - implications for pulmonary arterial hypertension.

Authors:  Jan K Hennigs; Nicole Lüneburg; Annett Stage; Melanie Schmitz; Jakob Körbelin; Lars Harbaum; Christiane Matuszcak; Julia Mienert; Carsten Bokemeyer; Rainer H Böger; Rainer Kiefmann; Hans Klose
Journal:  Purinergic Signal       Date:  2019-08-08       Impact factor: 3.765

2.  Viable Allogeneic Mitochondria Transplantation Improves Gas Exchange and Alveolar-Capillary Permeability in Rats with Endotoxin-Induced Acute Lung Injuries.

Authors:  Yu-Li Pang; Shi-Yuan Fang; Tzu-Ting Cheng; Chien-Chi Huang; Ming-Wei Lin; Chen-Fuh Lam; Kuen-Bao Chen
Journal:  Int J Med Sci       Date:  2022-06-06       Impact factor: 3.642

Review 3.  Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology.

Authors:  Gérald Simonneau; Peter Dorfmüller; Christophe Guignabert; Olaf Mercier; Marc Humbert
Journal:  Ann Cardiothorac Surg       Date:  2022-03

4.  Endothelial Extracellular Vesicles in Pulmonary Function and Disease.

Authors:  Eleftheria Letsiou; Natalie Bauer
Journal:  Curr Top Membr       Date:  2018-10-08       Impact factor: 3.049

Review 5.  Molecular Mechanisms of Vascular Damage During Lung Injury.

Authors:  Ramon Bossardi Ramos; Alejandro Pablo Adam
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Authors:  Alice Huertas; David Montani; Laurent Savale; Jérémie Pichon; Ly Tu; Florence Parent; Christophe Guignabert; Marc Humbert
Journal:  Eur Respir J       Date:  2020-07-30       Impact factor: 16.671

7.  Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention.

Authors:  Gabriele Grunig; Christina A Eichstaedt; Jeremias Verweyen; Nedim Durmus; Stephanie Saxer; Greta Krafsur; Kurt Stenmark; Silvia Ulrich; Ekkehard Grünig; Serhiy Pylawka
Journal:  Front Physiol       Date:  2018-07-25       Impact factor: 4.566

8.  Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.

Authors:  Marc Humbert; Christophe Guignabert; Sébastien Bonnet; Peter Dorfmüller; James R Klinger; Mark R Nicolls; Andrea J Olschewski; Soni S Pullamsetti; Ralph T Schermuly; Kurt R Stenmark; Marlene Rabinovitch
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

Review 9.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

10.  Experimental animal models of pulmonary hypertension: Development and challenges.

Authors:  Xiao-Han Wu; Jie-Ling Ma; Dong Ding; Yue-Jiao Ma; Yun-Peng Wei; Zhi-Cheng Jing
Journal:  Animal Model Exp Med       Date:  2022-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.